# 바이오스페이스 일일 뉴스 리포트 - 2025년 04월 23일


## 주요 헤드라인

1. **Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/stoffels-to-depart-galapagos-short-of-five-year-mission-to-remake-the-biotech>

2. **Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/stoffels-to-depart-galapagos-short-of-five-year-mission-to-remake-the-biotech>

3. **Pfizer Mounts Defense of Cardiac Blockbuster as Alnylam, BridgeBio Enter Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-mounts-defense-of-cardiac-blockbuster-as-alnylam-bridgebio-enter-market>

4. **Pfizer Mounts Defense of Cardiac Blockbuster as Alnylam, BridgeBio Enter Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-mounts-defense-of-cardiac-blockbuster-as-alnylam-bridgebio-enter-market>

5. **Roche, Regeneron Pledge Multibillion Boosts to US Manufacturing as Trump’s Tariffs Loom (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/roche-regeneron-pledge-multibillion-boosts-to-us-manufacturing-as-trumps-tariffs-loom>

6. **Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/gileads-trodelvy-with-keytruda-slows-disease-progression-in-triple-negative-breast-cancer>

7. **AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/astrazeneca-daiichi-sankyo-push-enhertu-to-frontline-breast-cancer-with-phase-iii-data>


---
*2025년 04월 23일 바이오스페이스 뉴스 피드에서 생성된 리포트*